Clinical Trials Directory

Trials / Completed

CompletedNCT00182390

Premature Infants in Need of Transfusion (PINT)

A Randomized Controlled Trial of Two Hemoglobin Thresholds for Transfusion in Newborns <1000g Birth Weight

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
424 (planned)
Sponsor
McMaster University · Academic / Other
Sex
All
Age
48 Hours
Healthy volunteers
Not accepted

Summary

Hypothesis: That a high hemoglobin threshold for transfusion in extremely low birth weight (ELBW) infants is associated with a lower rate of survival without severe morbidity (defined as one or more of retinopathy of prematurity, bronchopulmonary dysplasia, or periventricular leukomalacia/ventriculomegaly). Primary Objective: To determine whether either a liberal or more restrictive threshold of hemoglobin level for red cell transfusion in ELBW infants is safer, by randomizing to either a high transfusion hemoglobin threshold or a low transfusion hemoglobin threshold. Follow-up at a corrected age of 18 months represents a conventional age at which to first assess neurodevelopmental outcomes, and to predict long-term outcomes.

Conditions

Interventions

TypeNameDescription
PROCEDURERed blood cell transfusion

Timeline

Start date
2001-02-01
Primary completion
2003-02-01
Completion
2005-11-01
First posted
2005-09-16
Last updated
2015-09-24

Locations

10 sites across 3 countries: United States, Australia, Canada

Source: ClinicalTrials.gov record NCT00182390. Inclusion in this directory is not an endorsement.